Literature DB >> 21839798

One year oral Toxicity of D-004, a lipid extract from Roystonea regia fruits, in Sprague Dawley rats.

A Gutiérrez1, R Gámez, M Noa, R Mas, D Arencibia, B Pardo, M Valle, A Oyarzábal, D Curveco, H García, E Goicochea, N Mendoza, S Jiménez.   

Abstract

D-004, a lipid extract of royal palm (Roystonea regia) fruits that contains a reproducible mixture of fatty acids, has been shown to prevent testosterone and phenylephrine-induced prostate hyperplasia in rodents. This study investigated the long-term oral toxicity of D-004 in rats. Rats from both sexes were randomized into four groups (20 rats sex/group): a control and three treated with D-004 (800, 1500 or 2000 mg/kg/day, respectively). At study completion, rats were sacrificed under anaesthesia. Determinations of blood biochemical and haematological parameters and organ weight were done. Also, necropsy and histopathological studies were performed. Four of 160 rats died before study completion. No clinical signs of toxicity were observed throughout the study. Food and water consumption, bodyweight, blood biochemical and haematological parameters, organ weight ratios and histopathological findings were similar in control and treated groups. The histological lesions found in treated animals are commonly present in this specie and strain according to literature and our historical data. In conclusion, long-term (12 months) oral treatment of rats with D-004 (800-2000 mg/kg/day) did not show evidences of D-004-related toxicity under our conditions. The highest dose tested (2000 mg/kg) was a no-observed adverse effect level in this study.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839798     DOI: 10.1016/j.fct.2011.07.061

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  3 in total

1.  Preclinical Safety of the Root Extract of Polygala tenuifolia Willdenow in Sprague-Dawley Rats and Beagle Dogs.

Authors:  Ki Young Shin; Beom Young Won; Hyun Jee Ha; Yeo Sang Yun; Hyung Gun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-05       Impact factor: 2.629

2.  Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study.

Authors:  Raúl Guzmán; Julio C Fernández; Manuel Pedroso; Lilia Fernández; José Illnait; Sarahí Mendoza; Ana T Quiala; Zunilda Rodríguez; Jilma Mena; Aylim Rodíguez; Marbelis Campos; Carlos Sánchez; Yanet Alvarez; Gladys Jiménez
Journal:  Ther Adv Urol       Date:  2019-06-11

Review 3.  Treatment of Benign Prostatic Hyperplasia by Natural Drugs.

Authors:  Eszter Csikós; Adrienn Horváth; Kamilla Ács; Nóra Papp; Viktória Lilla Balázs; Marija Sollner Dolenc; Maša Kenda; Nina Kočevar Glavač; Milan Nagy; Michele Protti; Laura Mercolini; Györgyi Horváth; Ágnes Farkas
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.